Osteopathic Manipulative Therapy May Modulate Immune Activity in Chronic Low Back Pain
Overview
Chronic low back pain (CLBP) involves immune-mediated neuroinflammatory mechanisms contributing to persistent pain. Osteopathic manipulative therapy (OMT) may influence immune cell gene expression and distribution, potentially reducing inflammation and neuroimmune sensitization, thereby alleviating pain.
Background
CLBP is a leading cause of disability worldwide, often managed with medications that carry significant side effects. Both peripheral immune activation and central nervous system sensitization contribute to CLBP pathophysiology. OMT, a non-invasive manual therapy, has demonstrated efficacy in reducing pain and improving function, but its underlying biological mechanisms remain unclear. Emerging evidence suggests immune modulation may be a key mechanism by which OMT exerts therapeutic effects.
Data Highlights
OMT applies mechanical forces that may alter leukocyte trafficking and cytokine activity, leading to transcriptomic changes in peripheral blood mononuclear cells. These changes could reduce pro-inflammatory cytokine production (e.g., TNF-α, IL-1β, IL-6) and reprogram immune responses, influencing pain pathways. Meta-analyses support OMT's efficacy in CLBP, but direct transcriptomic validation is limited and requires further study.
Key Findings
Chronic pain involves persistent inflammation mediated by immune cells releasing pro-inflammatory cytokines that sensitize nociceptors.
OMT mechanically influences lymphatic and neurovascular structures, potentially shifting immune cell proportions and activation states.
Transcriptomic alterations in circulating immune cells after OMT may reduce cytokine production and modulate immune responses.
Immune modulation by OMT could affect central nervous system pathways involved in pain perception and sensitization.
Current evidence supports OMT's clinical efficacy in CLBP but lacks direct mechanistic transcriptomic validation.
Clinical Implications
OMT represents a promising non-pharmacological intervention for CLBP that may reduce reliance on NSAIDs and opioids, minimizing associated risks. Understanding OMT's immune-modulating effects could guide personalized treatment strategies targeting neuroimmune mechanisms in chronic pain. Further mechanistic studies are needed to validate immune biomarkers and optimize OMT protocols.
Conclusion
OMT may alleviate chronic low back pain by modulating immune cell activity and inflammatory signaling, offering a novel mechanistic insight into its therapeutic benefits. This hypothesis warrants further investigation to confirm transcriptomic changes and refine clinical applications.
References
National Institutes of Health HEAL Initiative 2018 -- Advancing Chronic Pain Strategies
Meta-analyses 2011-2018 -- Efficacy of Osteopathic Manipulative Therapy in CLBP
Recent Pain Research 2019-2023 -- Immune System Role in Chronic Pain
by Lily Tehrani, Jackson Gamer, Sarah Ballarin, Sebastian Arango, Nathan Widboom, Patrick Barry, Mark Sandhouse, Jill Wallace-Ross, Yasmin Qureshi, Lubov Nathanson
A small observational study in collegiate football players found microbiome associations after nonconcussive head impacts, though findings were limited by severe underpowering and high attrition
A long-term cohort study found that obesity was not associated with worse patient-reported outcomes or higher reoperation rates following total ankle replacement in optimized surgical candidates.
